Evidence map›Paper›PMID 37396046›Full record

ArticleFrontiers in genetics2023

Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs.

Yongfeng Wang, Dongzhi Zhang, Yuxi Li, Yue Wu, Haizhong Ma, Xianglai Jiang, Liangyin Fu, Guangming Zhang, Haolan Wang, Xingguang Liu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yongfeng WangThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Dongzhi ZhangThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Yuxi LiThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Yue WuThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Haizhong MaKey Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, Gansu, China.
Xianglai JiangGeneral Surgery Clinical Medical Center, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Liangyin FuGeneral Surgery Clinical Medical Center, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Guangming ZhangThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Haolan WangGeneral Surgery Clinical Medical Center, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Xingguang LiuThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Hui CaiThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colon cancerimmune landscapem6A-related lncRNAsprognostic signaturestumor immune microenvironment

Identifiers

PMID37396046
PMCPMC10313068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.